Literature DB >> 16546353

Up-regulation of a serine-threonine kinase proto-oncogene Pim-1 in oral squamous cell carcinoma.

W-F Chiang1, C-Y Yen, C-N Lin, G-A Liaw, C-T Chiu, Y-J Hsia, S-Y Liu.   

Abstract

The Pim-1 proto-oncogene, encoding a serine-threonine kinase, has been found to play an important role in regulating apoptosis, differentiation, proliferation and tumourigenesis. The present study was conducted to assess the importance of Pim-1 in oral tumourigenesis in vivo. Reverse transcriptase-polymerase chain reaction and immunohistochemistry were used to study the expression of Pim-1 in oral squamous cell carcinoma (OSCC) and non-cancerous match tissue (NCMT) sampled from the periphery of the tumours. Pim-1 mRNA expression in OSCC was significantly higher than that in NCMT in 36 tissue pairs (1.33+/-0.41 versus 0.97+/-0.29, P=0.03). The percentage of OSCCs exhibiting strong cytoplasmic Pim-1 immunoreactivity was significantly higher than that of NCMT (60% versus 19%, P=0.007). Pim-1 immunoreactivity is higher in the more differentiated components of a tumour. In around 10% of OSCC cases, Pim-1 immunoreactivity was found in the nucleus as well. These results show novel findings of the up-regulation of Pim-1 expression from NCMT to OSCC. The pathogenetic role of Pim-1 expression in oral tumourigenesis deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546353     DOI: 10.1016/j.ijom.2006.01.027

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  20 in total

Review 1.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

2.  Pim-1 kinase expression predicts radiation response in squamocellular carcinoma of head and neck and is under the control of epidermal growth factor receptor.

Authors:  Katriina Peltola; Maija Hollmen; Sanna-Mari Maula; Eeva Rainio; Raija Ristamäki; Marjaana Luukkaa; Jouko Sandholm; Maria Sundvall; Klaus Elenius; Päivi J Koskinen; Reidar Grenman; Sirpa Jalkanen
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

3.  RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.

Authors:  Jolyane Meloche; Roxane Paulin; Audrey Courboulin; Caroline Lambert; Marjorie Barrier; Pierre Bonnet; Malik Bisserier; Mélanie Roy; Mark A Sussman; Mohsen Agharazii; Sébastien Bonnet
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-16       Impact factor: 8.311

4.  Expression of proviral integration site for Moloney murine leukemia virus 1 (Pim-1) is post-transcriptionally regulated by tristetraprolin in cancer cells.

Authors:  Hong Kyeung Kim; Chae Won Kim; Mai-Tram Vo; Hyun Hee Lee; Ji Young Lee; Nal Ae Yoon; Chae Yeong Lee; Chang Hoon Moon; Young Joo Min; Jeong Woo Park; Wha Ja Cho
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

5.  PIM1 gene cooperates with human BCL6 gene to promote the development of lymphomas.

Authors:  Beverly W Baron; John Anastasi; Elizabeth M Hyjek; Juraj Bies; Poluru L Reddy; Jingfang Dong; Loren Joseph; Michael J Thirman; Kristen Wroblewski; Linda Wolff; Joseph M Baron
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

6.  Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension.

Authors:  Roxane Paulin; Audrey Courboulin; Jolyane Meloche; Vincent Mainguy; Eric Dumas de la Roque; Nehmé Saksouk; Jacques Côté; Steeve Provencher; Mark A Sussman; Sébastien Bonnet
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

7.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

8.  Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach.

Authors:  Mingfeng Shao; Yiming Yuan; Kun Yu; Kai Lei; Guonian Zhu; Lijuan Chen; Mingli Xiang
Journal:  Mol Divers       Date:  2014-02-12       Impact factor: 2.943

9.  Human papillomavirus insertions identify the PIM family of serine/threonine kinases as targetable driver genes in head and neck squamous cell carcinoma.

Authors:  Tatevik R Broutian; Bo Jiang; Jingfeng Li; Keiko Akagi; Shanying Gui; Zhengqiu Zhou; Weihong Xiao; David E Symer; Maura L Gillison
Journal:  Cancer Lett       Date:  2020-01-17       Impact factor: 8.679

Review 10.  The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension.

Authors:  Inés Roger; Javier Milara; Paula Montero; Julio Cortijo
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.